subgroup of
drug)
→
ReceivesAction
→
approved by the fda
| Typicality: | 0.764 |
| Saliency: | 0.950 |
| between 2000 | 11 | temporal |
| in 2002 | 11 | temporal |
| in the us | 11 | location |
| new drug → be approved by → the fda | 105 |
| new drug → be approved by → the food and drug administration | 23 |
| new drug → be approved by → fda | 15 |
| negative | neutral | positive |
| 0.123 | 0.565 | 0.311 |
| Raw frequency | 143 |
| Normalized frequency | 0.950 |
| Modifier score | 0.833 |
| Perplexity | 68.083 |